Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s disease

被引：0
作者：
Umesh Gangishetti
J. Christina Howell
Richard J. Perrin
Natalia Louneva
Kelly D. Watts
Alexander Kollhoff
Murray Grossman
David A. Wolk
Leslie M. Shaw
John C. Morris
John Q. Trojanowski
Anne M. Fagan
Steven E. Arnold
William T. Hu
机构：
[1] Emory University,Department of Neurology
[2] Emory University,Department of Alzheimer’s Disease Research Center
[3] Washington University,Knight Alzheimer’s Disease Research Center
[4] Washington University,Department of Pathology
[5] Washington University,Department of Neurology
[6] University of Pennsylvania,Penn Memory Center
[7] University of Pennsylvania,Center for Neurodegenerative Disease Research
[8] University of Pennsylvania,Penn FTD Center
[9] University of Pennsylvania,Department of Neurology
[10] University of Pennsylvania,Department of Pathology and Laboratory Medicine
[11] Present Address: Massachusetts General Hospital,undefined
来源：
Alzheimer's Research & Therapy | / 10卷
关键词：
Biomarkers; Fatty acid binding protein; Interleukin-10; Mild cognitive impairment; Neurofilament light chain;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer's disease
    Gunnarsson, Malin Degerman
    Ingelsson, Martin
    Blennow, Kaj
    Basun, Hans
    Lannfelt, Lars
    Kilander, Lena
    ALZHEIMERS RESEARCH & THERAPY, 2016, 8
  • [32] Blood Beta-Amyloid and Tau in Down Syndrome: A Comparison with Alzheimer's Disease
    Lee, Ni-Chung
    Yang, Shieh-Yueh
    Chieh, Jen-Jie
    Huang, Po-Tsang
    Chang, Lih-Maan
    Chiu, Yen-Nan
    Huang, Ai-Chiu
    Chien, Yin-Hsiu
    Hwu, Wuh-Liang
    Chiu, Ming-Jang
    FRONTIERS IN AGING NEUROSCIENCE, 2017, 8
  • [33] Cerebrospinal fluid BACE1 activity and markers of amyloid precursor protein metabolism and axonal degeneration in Alzheimer's disease
    Perneczky, Robert
    Alexopoulos, Panagiotis
    ALZHEIMERS & DEMENTIA, 2014, 10 (05) : S425 - +
  • [34] Cerebrospinal Fluid Amyloid Beta and Tau Concentrations Are Not Modulated by 16 Weeks of Moderate- to High-Intensity Physical Exercise in Patients with Alzheimer Disease
    Jensen, Camilla Steen
    Portelius, Erik
    Siersnia, Volkert
    Hogh, Peter
    Wermuth, Lene
    Blennow, Kaj
    Zetterberg, Henrik
    Waldemar, Gunhild
    Hasselbalch, Steen Gregers
    Sinionsen, Anja Hviid
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2016, 42 (3-4) : 146 - 158
  • [35] Prognostic value of amyloid/tau/neurodegeneration (ATN) classification based on diagnostic cerebrospinal fluid samples for Alzheimer’s disease
    Koen Delmotte
    Jolien Schaeverbeke
    Koen Poesen
    Rik Vandenberghe
    Alzheimer's Research & Therapy, 13
  • [36] Cerebrospinal Fluid sTREM2 in Alzheimer's Disease Is Associated with Both Amyloid and Tau Pathologies but not with Cognitive Status
    Li, Tao-Ran
    Lyu, Di-Yang
    Liu, Feng-Qi
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 90 (03) : 1123 - 1138
  • [37] Increased Cerebrospinal Fluid Tau Levels in Logopenic Variant of Alzheimer's Disease
    Magnin, Eloi
    Paquet, Claire
    Formaglio, Maite
    Croisile, Bernard
    Chamard, Ludivine
    Miguet-Alfonsi, Carole
    Tio, Gregory
    Dumurgier, Julien
    Roullet-Solignac, Isabelle
    Sauvee, Mathilde
    Thomas-Anterion, Catherine
    Vighetto, Alain
    Hugon, Jacques
    Vandel, Pierre
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 39 (03) : 611 - 616
  • [38] Amyloid-β(1-42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease
    Mulder, Cees
    Verwey, Nicolaas A.
    van der Flier, Wiesje M.
    Bouwman, Femke H.
    Kok, Astrid
    van Elk, Evert J.
    Scheltens, Philip
    Blankenstein, Marinus A.
    CLINICAL CHEMISTRY, 2010, 56 (02) : 248 - 253
  • [39] Cerebrospinal fluid biomarkers of Alzheimer's disease
    Fagan, Anne M.
    Holtzman, David M.
    BIOMARKERS IN MEDICINE, 2010, 4 (01) : 51 - 63
  • [40] Cerebrospinal fluid biomarkers in Alzheimer's disease
    Hugon, Jacques
    Dumurgier, Julien
    Cognat, Emmanuel
    Paquet, Claire
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2018, 202 (1-2): : 307 - 318
12345